MMP2 and ameloblastoma: In summary, these data indicate that siRNA targeting of MMP-2 mRNA or TIMP-2 overxpression using a plasmid-based system effectively inhibited the activity of MMP-2 in ameloblastoma cells, which subsequently resulted in reduced ameloblastoma cell invasiveness in vitro.